Sometime in the future, probably in the near future, many people will have access to individual molecular profiles, which will lead to the devolpement of personalized medicine. With this and the the continued study of the molecular basis of diseases, the pharmaceutical industry will be changed dramtaically. This article also addresses the fact that trial and error medicine may be approaching the end, because with personalized medicine we will already know what's going to happen and why; we will know what molecular targets we have to target for certain therapies, based on the indivduals molecular profile. How much will it cost to have these molecular profiles? Will health insurance change dramatically? There are many questions that arise with this growing popularity of personailzed medicine.
The article also states that clinical diagnosed diseases will be replaced by genetic markers. Instead of clinical signs and symptoms to diagnose diseases, we will have these molecular profiles. We are on our way to a safer and more effective way of treating diseases. The article also states: Personalized medicine promises to offer the right treatment for the right patient at the right time.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment